{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T16:19:43Z","timestamp":1784391583362,"version":"3.55.0"},"reference-count":35,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,3,21]],"date-time":"2024-03-21T00:00:00Z","timestamp":1710979200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec><jats:title>Purpose<\/jats:title><jats:p>Despite the increase in socio-health conditions and, in general, the focus on health worldwide, many diseases still adversely affect the quality of life (QoL), including those causing vision loss. The main purpose of this study was to evaluate the QoL of people with visual impairments through a questionnaire and identify issues concerning everyday life in the urban and extra-urban areas of Turin.<\/jats:p><\/jats:sec><jats:sec><jats:title>Patients and methods<\/jats:title><jats:p>A personalized questionnaire including 25 questions was distributed to 100 enrolled patients. It was designed by integrating the most widely used questionnaires related to the QoL of people with visual impairment with questions concerning the city of Turin. The inclusion criteria were any degree of visual impairment (from mild defect to complete blindness), according to Law n. 138\/2001 classification. The exclusion criteria were mental disability and residence in care homes. Finally, statistical analysis was performed. Pearson\u2019s Chi-Square test was used to evaluate the strength of the association between two qualitative variables in different sections of the questionnaire. The results were classified as statistically significant with a <jats:italic>p<\/jats:italic>-value of \u22640.05 or borderline (0.05\u2009&amp;lt;\u2009<jats:italic>p<\/jats:italic>-value&amp;lt;0.10).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Based on responses to question 7 (Q7), 67% of selected patients stated that sight markedly influences their QoL. Moreover, 49% of patients responding to question 12 considered themselves almost completely dependent on other people regarding mobility and movement in and around Turin. In total, 57% used public transport (Q13); however, 50% of them found it challenging to access (Q14). Personal aids (e.g., white cane and magnifying glasses) were adopted only by 51% (Q15), and 63% of patients responding to question 18 suggested a refinement of urban aids (e.g., road signs). Of the 53 patients, 30 patients (56.6%) considered Turin a livable city for visually impaired people (Q19); however, 44 patients (84.6%) reported no significant improvements in Turin\u2019s urban logistics during the last 5\u2009years and highlighted the urgent need to improve urban aids (Q21). Furthermore, the statistical associations studied showed that the loss of vision plays a significant role in influencing the perception of one\u2019s QoL (association of questions 7 and 8, X2\u2009=\u2009112.119, Cramer\u2019s V\u2009=\u20090.548, <jats:italic>p<\/jats:italic>-value &amp;lt;0.001). In addition, it is more difficult for visually impaired patients living outside the city to move outdoors (Chi-Square\u2009=\u200910.637, Cramer\u2019s V\u2009=\u20090.326, <jats:italic>p<\/jats:italic> \u2212\u2009245 value\u2009=\u20090.031) and to cross the street (Chi-Square\u2009=\u200914.102, Cramer\u2019s V\u2009=\u20090.376, p-250 value\u2009=\u20090.007). Finally, those who feel independent perceive their lives to be more fulfilling (Chi-Square\u2009=\u2009268, X2\u2009=\u200937.433; Cramer\u2019s V\u2009=\u20090.306, <jats:italic>p<\/jats:italic> value\u2009=\u20090.002).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Our study showed how vision loss plays a remarkable role in influencing the perception of one\u2019s QoL. Furthermore, it highlighted how the implementation of mobility and the use of personal aids for living in a city, such as Turin, were associated with a better perception of QoL by visually impaired patients. However, it is necessary to improve urban technological development according to the needs of people with visual disability.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmed.2024.1361631","type":"journal-article","created":{"date-parts":[[2024,3,21]],"date-time":"2024-03-21T04:55:14Z","timestamp":1710996914000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["Blindness and visual impairment: quality of life and accessibility in the city of Turin"],"prefix":"10.3389","volume":"11","author":[{"given":"Alessia","family":"Nuzzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Becco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Boschiroli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Coletto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaele","family":"Nuzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,3,21]]},"reference":[{"key":"ref1","year":"2019"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1001\/archopht.122.4.615","article-title":"VISION 2020: the right to sight: a global initiative to eliminate avoidable blindness","volume":"122","author":"Pizzarello","year":"2004","journal-title":"Arch Ophthalmol"},{"key":"ref3","year":"2013"},{"key":"ref4","year":"2013"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"e130","DOI":"10.1016\/S2214-109X(20)30425-3","article-title":"Trends in prevalence of blindness and distance and near vision impairment over 30 years: an analysis for the global burden of disease study","volume":"9","author":"Bourne","year":"2021","journal-title":"Lancet Glob Health"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"e144","DOI":"10.1016\/S2214-109X(20)30489-7","article-title":"Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the right to sight: an analysis for the global burden of disease study","volume":"9","author":"Steinmetz","year":"2021","journal-title":"Lancet Glob Health"},{"key":"ref7","volume-title":"Constitution of the world health organization","year":"2005"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1037\/0278-6133.1.1.61","article-title":"Health-related quality of life measurement for evaluation research and policy analysis","volume":"1","author":"Kaplan","year":"1982","journal-title":"Health Psychol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"e489","DOI":"10.1016\/S2214-109X(20)30488-5","article-title":"The lancet Global Health Commission on global eye health: vision beyond 2020","volume":"9","author":"Burton","year":"2021","journal-title":"Lancet Glob Health"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/S0002-9394(02)02110-4","article-title":"The magnitude and cost of global blindness: an increasing problem that can be alleviated","volume":"135","author":"Frick","year":"2003","journal-title":"Am J Ophthalmol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1001\/archopht.124.12.1754","article-title":"The economic burden of major adult visual disorders in the United States","volume":"124","author":"Rein","year":"2006","journal-title":"Arch Ophthalmol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1159\/000316688","article-title":"Impact of low vision on employment","volume":"224","author":"Mojon-Azzi","year":"2010","journal-title":"Ophthalmologica"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1080\/17441692.2011.634815","article-title":"An estimation of the worldwide economic and health burden of visual impairment","volume":"7","author":"Gordois","year":"2012","journal-title":"Glob Public Health"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1016\/j.ophtha.2015.04.014","article-title":"The global burden of potential productivity loss from uncorrected presbyopia","volume":"122","author":"Frick","year":"2015","journal-title":"Ophthalmology"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"349","DOI":"10.3109\/09286586.2015.1066394","article-title":"A simple method for estimating the economic cost of productivity loss due to blindness and moderate to severe visual impairment","volume":"22","author":"Eckert","year":"2015","journal-title":"Ophthalmic Epidemiol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"100852","DOI":"10.1016\/j.eclinm.2021.100852","article-title":"Global economic productivity losses from vision impairment and blindness","volume":"35","author":"Marques","year":"2021","journal-title":"EClinicalMedicine"},{"key":"ref17","first-page":"2317","article-title":"Global prevalence of blindness and distance and near vision impairment in 2020: progress towards the vision 2020 targets and what the future holds","volume":"61","author":"Bourne","year":"2020","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"e1221","DOI":"10.1016\/S2214-109X(17)30393-5","article-title":"Global causes of blindness and distance vision impairment 1990-2020: a systematic review and meta-analysis","volume":"5","author":"Flaxman","year":"2017","journal-title":"Lancet Glob Health"},{"key":"ref19","year":""},{"key":"ref20","author":"Legge","year":"2001"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/S0002-9394(00)00610-3","article-title":"Design of the low vision quality-of-life questionnaire (LVQOL) and measuring the outcome of low-vision rehabilitation","volume":"130","author":"Wolffsohn","year":"2000","journal-title":"Am J Ophthalmol"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1001\/archopht.119.7.1050","article-title":"Development of the 25-item National eye Institute visual function questionnaire","volume":"119","author":"Mangione","year":"2001","journal-title":"Arch Ophthalmol"},{"key":"ref23","first-page":"927","article-title":"Assessment of the impact of vision impairment","volume":"43","author":"Weih","year":"2002","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1001\/archopht.1994.01090170074026","article-title":"The VF-14: an index of functional impairment in patients with cataract","volume":"112","author":"Steinberg","year":"1994","journal-title":"Arch Ophthalmol"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.2147\/OPTH.S174006","article-title":"Low vision, visual impairments and metropolitan urban planning: example of a topographic enhancement, need and monitoring in an Italian city","volume":"12","author":"Nuzzi","year":"2018","journal-title":"Clin Ophthalmol"},{"key":"ref26","volume-title":"Health measurement scales: A practical guide to their development and use","author":"Streiner","year":"1995"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/BF02310555","article-title":"Coefficient alpha and the internal structure of tests","volume":"16","author":"Cronbach","year":"1951","journal-title":"Psychometrika"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1016\/j.ophtha.2006.04.028","article-title":"Impact of severity and bilaterality of visual impairment on health-related quality of life","volume":"113","author":"Varma","year":"2006","journal-title":"Ophthalmology"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1001\/jamaophthalmol.2016.1778","article-title":"Visual function, social position, and health and life chances: the UK biobank study","volume":"134","author":"Cumberland","year":"2016","journal-title":"JAMA Ophthalmol"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1007\/s11136-011-0061-y","article-title":"The impact of low vision on activities of daily living, symptoms of depression, feelings of anxiety and social support in community-living older adults seeking vision rehabilitation services","volume":"21","author":"Kempen","year":"2012","journal-title":"Qual Life Res"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1167\/iovs.14-15848","article-title":"Major depressive and anxiety disorders in visually impaired older adults","volume":"56","author":"van der Aa","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1136\/bjophthalmol-2019-314422","article-title":"Prevalence and incidence of age-related macular degeneration in Europe: a systematic review and meta-analysis","volume":"104","author":"Li","year":"2020","journal-title":"Br J Ophthalmol"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"428","DOI":"10.3109\/09638288.2016.1146353","article-title":"Health-related quality of life in working-age adults with visual impairments in Germany","volume":"39","author":"Schliermann","year":"2017","journal-title":"Disabil Rehabil"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.ophtha.2006.10.006","article-title":"Depression and anxiety in visually impaired older people","volume":"114","author":"Evans","year":"2007","journal-title":"Ophthalmology"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1111\/j.1532-5415.1998.tb01080.x","article-title":"Depression and disability associated with impaired vision: the MoVies project","volume":"46","author":"Rovner","year":"1998","journal-title":"J Am Geriatr Soc"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2024.1361631\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,21]],"date-time":"2024-03-21T04:55:17Z","timestamp":1710996917000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2024.1361631\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,21]]},"references-count":35,"alternative-id":["10.3389\/fmed.2024.1361631"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2024.1361631","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,21]]},"article-number":"1361631"}}